-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : WELLS FARGO CUTS TARGET PRICE TO $253 FROM $256

Reuters·10/14/2026 10:39:07

Please log in to view news